Galmed Pharmaceuticals Ltd. Files Annual Report on Form 20-F for the Fiscal Year Ended December 31, 2025

Go back to Galmed Pharmaceuticals Ltd. Files Annual Report on Form 20-F for the Fiscal Year Ended December 31, 2025
GALMED PHARMACEUTIC (NASDAQ: GLMD) Delayed: 0.56 --0 (-0%)
Previous Close $0.56    52 Week High $9.70 
Open $0.56    52 Week Low $2.78 
Day High $0.56    P/E N/A 
Day Low $0.56    EPS $0.00 
Volume 293